These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16082413)

  • 1. Targeting drug-efflux pumps -- a pharmacoinformatic approach.
    Pleban K; Kaiser D; Kopp S; Peer M; Chiba P; Ecker GF
    Acta Biochim Pol; 2005; 52(3):737-40. PubMed ID: 16082413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-glycoprotein substrate binding domains are located at the transmembrane domain/transmembrane domain interfaces: a combined photoaffinity labeling-protein homology modeling approach.
    Pleban K; Kopp S; Csaszar E; Peer M; Hrebicek T; Rizzi A; Ecker GF; Chiba P
    Mol Pharmacol; 2005 Feb; 67(2):365-74. PubMed ID: 15509712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of ligand-binding regions of P-glycoprotein by activated-pharmacophore photoaffinity labeling and matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry.
    Ecker GF; Csaszar E; Kopp S; Plagens B; Holzer W; Ernst W; Chiba P
    Mol Pharmacol; 2002 Mar; 61(3):637-48. PubMed ID: 11854445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A three-dimensional model for the substrate binding domain of the multidrug ATP binding cassette transporter LmrA.
    Ecker GF; Pleban K; Kopp S; Csaszar E; Poelarends GJ; Putman M; Kaiser D; Konings WN; Chiba P
    Mol Pharmacol; 2004 Nov; 66(5):1169-79. PubMed ID: 15304548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaustive sampling of docking poses reveals binding hypotheses for propafenone type inhibitors of P-glycoprotein.
    Klepsch F; Chiba P; Ecker GF
    PLoS Comput Biol; 2011 May; 7(5):e1002036. PubMed ID: 21589945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2.
    Shukla S; Robey RW; Bates SE; Ambudkar SV
    Drug Metab Dispos; 2009 Feb; 37(2):359-65. PubMed ID: 18971320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photoaffinity labeling of P-glycoprotein.
    Peer M; Csaszar E; Vorlaufer E; Kopp S; Chiba P
    Mini Rev Med Chem; 2005 Feb; 5(2):165-72. PubMed ID: 15720286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships, ligand efficiency, and lipophilic efficiency profiles of benzophenone-type inhibitors of the multidrug transporter P-glycoprotein.
    Jabeen I; Pleban K; Rinner U; Chiba P; Ecker GF
    J Med Chem; 2012 Apr; 55(7):3261-73. PubMed ID: 22452412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramolecular distribution of hydrophobicity influences pharmacological activity of propafenone-type MDR modulators.
    Pleban K; Hoffer C; Kopp S; Peer M; Chiba P; Ecker GF
    Arch Pharm (Weinheim); 2004 Jun; 337(6):328-34. PubMed ID: 15188222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction field based and hologram based QSAR analysis of propafenone-type modulators of multidrug resistance.
    Kaiser D; Smiesko M; Kopp S; Chiba P; Ecker GF
    Med Chem; 2005 Sep; 1(5):431-44. PubMed ID: 16787327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies.
    Mora Lagares L; Minovski N; Caballero Alfonso AY; Benfenati E; Wellens S; Culot M; Gosselet F; Novič M
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of gatifloxacin with efflux transporters: a possible mechanism for drug resistance.
    Kwatra D; Vadlapatla RK; Vadlapudi AD; Pal D; Mitra AK
    Int J Pharm; 2010 Aug; 395(1-2):114-21. PubMed ID: 20573570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and ligand-based design of P-glycoprotein inhibitors: a historical perspective.
    Palmeira A; Sousa E; Vasconcelos MH; Pinto M; Fernandes MX
    Curr Pharm Des; 2012; 18(27):4197-214. PubMed ID: 22827485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacoinformatic approaches to design natural product type ligands of ABC-transporters.
    Klepsch F; Jabeen I; Chiba P; Ecker GF
    Curr Pharm Des; 2010 May; 16(15):1742-52. PubMed ID: 20222855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both ATP sites of human P-glycoprotein are essential but not symmetric.
    Hrycyna CA; Ramachandra M; Germann UA; Cheng PW; Pastan I; Gottesman MM
    Biochemistry; 1999 Oct; 38(42):13887-99. PubMed ID: 10529234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propafenone analogue with additional H-bond acceptor group shows increased inhibitory activity on P-glycoprotein.
    Cseke A; Schwarz T; Jain S; Decker S; Vogl K; Urban E; Ecker GF
    Arch Pharm (Weinheim); 2020 Mar; 353(3):e1900269. PubMed ID: 31917466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-organizing maps for identification of new inhibitors of P-glycoprotein.
    Kaiser D; Terfloth L; Kopp S; Schulz J; de Laet R; Chiba P; Ecker GF; Gasteiger J
    J Med Chem; 2007 Apr; 50(7):1698-702. PubMed ID: 17352460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the dexniguldipine binding site in the multidrug resistance-related transport protein P-glycoprotein by photoaffinity labeling and mass spectrometry.
    Borchers C; Boer R; Klemm K; Figala V; Denzinger T; Ulrich WR; Haas S; Ise W; Gekeler V; Przybylski M
    Mol Pharmacol; 2002 Jun; 61(6):1366-76. PubMed ID: 12021398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lead identification for modulators of multidrug resistance based on in silico screening with a pharmacophoric feature model.
    Langer T; Eder M; Hoffmann RD; Chiba P; Ecker GF
    Arch Pharm (Weinheim); 2004 Jun; 337(6):317-27. PubMed ID: 15188221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs.
    Matsson P; Pedersen JM; Norinder U; Bergström CA; Artursson P
    Pharm Res; 2009 Aug; 26(8):1816-31. PubMed ID: 19421845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.